Merck & Co Inc (MRK)

MRK on New York Consolidated

59.16USD
22 Aug 2014
Price Change (% chg)

$0.31 (+0.53%)
Prev Close
$58.85
Open
$59.04
Day's High
$59.36
Day's Low
$58.90
Volume
3,272,690
Avg. Vol
8,286,431
52-wk High
$59.84
52-wk Low
$44.62

MRK

Chart for MRK

About

Merck & Co., Inc. (Merck), is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company consists of four operating segments, which are the Pharmaceut... (more)

Overall

Beta: 0.40
Market Cap (Mil.): $169,760.59
Shares Outstanding (Mil.): 2,884.63
Dividend: 0.44
Yield (%): 2.99

Financials

  MRK Industry Sector
P/E (TTM): 31.02 33.74 34.44
EPS (TTM): 1.90 -- --
ROI: 6.92 18.86 18.11
ROE: 11.71 19.48 18.84
Search Stocks

U.S. FDA approves Merck insomnia drug

WASHINGTON - The U.S. Food and Drug Administration said on Wednesday it has approved a new insomnia drug made by Merck & Co.

13 Aug 2014

UPDATE 2-U.S. FDA approves Merck insomnia drug

WASHINGTON, Aug 13 - The U.S. Food and Drug Administration said on Wednesday it has approved a new insomnia drug made by Merck & Co.

13 Aug 2014

U.S. FDA approves Merck insomnia drug

WASHINGTON, Aug 13 - The U.S. Food and Drug Administration said on Wednesday it has approved a new insomnia drug made by Merck & Co..

13 Aug 2014

US STOCKS-Wall Street ends down; Twitter rallies after-hours

* Merck up as results beat expectations, but Pfizer slips

29 Jul 2014

US STOCKS-Wall St edges lower on UPS outlook, telecom shares rally

* Merck up as results beat expectations, but Pfizer slips

29 Jul 2014

US STOCKS-Wall St flat as telecom gains offset by earnings

* Merck rises as results beat expectations, but Pfizer slips

29 Jul 2014

CORRECTED-US STOCKS-Wall St gains, telecoms sector lifted by Windstream

(Corrects paragraph 11 to show UPS is on Dow transportation index, not Dow industrials)

29 Jul 2014

Merck quarterly profit beats estimates; shares gain

- Merck & Co Inc reported better-than-expected quarterly results on Tuesday, helped by strong sales of consumer products and medicines for arthritis and HIV, sending its shares up more than 1 percent in morning trading.

29 Jul 2014

UPDATE 3-Merck quarterly profit beats estimates; shares gain

(Adds comments from CEO, analysts, details on drug pipeline)

29 Jul 2014

Wall Street to rise on earnings, data weighs

NEW YORK - U.S. stocks were set to rise slightly at the open on Tuesday following better-than-expected results from companies such as Pfizer and Merck and ahead of data on consumer sentiment.

29 Jul 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Wright Reports
$75.00
Provider: MarketLine (a Datamonitor Company)
$175.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks